Form 4: Balchem SVP Acquires Shares, Options
Insider Transaction Report
Balchem Corporation's SVP Chief Supply Chain Officer, Martin Luther Reid, reported the acquisition of restricted stock and performance units, alongside new stock options, and shares withheld for tax obligations.
Summary
- Martin Luther Reid, SVP Chief Supply Chain Officer of Balchem Corporation, reported several transactions.
- Acquired 940 shares of common stock as restricted stock on February 11, 2026, which vests over a three-year period (25% on the first anniversary, 25% on the second, and 50% on the third anniversary of the grant date).
- Acquired 2,359 shares of common stock on February 11, 2026, representing the vesting of performance stock units for the 2023-2025 performance period, including 39 dividend equivalent shares.
- 1,085 shares were withheld on February 11, 2026, at a price of $178.68 per share, to cover tax requirements upon the vesting of performance stock units.
- An additional 116 shares were withheld on February 12, 2026, at a price of $177.49 per share, to cover withholding taxes due upon the vesting of restricted shares granted on February 12, 2025.
- Acquired 3,400 stock options on February 11, 2026, with an exercise price of $178.68 and an expiration date of February 11, 2036, which vest over a three-year period (20% Year 1, 40% Year 2, and 40% Year 3).
- Following these transactions, direct beneficial ownership of common stock is 9,073 shares, and indirect ownership through a 401(k) Plan is 542 shares.
- Direct beneficial ownership of stock options is 3,400.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, representing routine executive compensation activities and tax-related share withholdings, which are standard practices and do not indicate a significant shift in company outlook or performance.
Positives
- Acquisition of 940 restricted shares, aligning management interests with shareholders through future vesting.
- Vesting of 2,359 performance stock units, reflecting the achievement of prior performance goals for the 2023-2025 period.
- Grant of 3,400 stock options, providing future incentive for value creation with an exercise price of $178.68.
Negatives
- 1,085 shares were withheld at $178.68 to cover tax obligations from the vesting of performance stock units.
- 116 shares were withheld at $177.49 to cover tax obligations from the vesting of restricted shares.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that these transactions represent routine executive compensation activities, including equity grants and vesting, which are common practices across industries to align management incentives with shareholder interests. This filing does not provide specific industry-wide insights beyond the company's compensation structure.
Stakeholder Impact
- Shareholders: Increased transparency regarding executive equity ownership and compensation structure.
- Reporting Person (Martin Luther Reid): Increased equity stake and long-term incentive through restricted stock and stock options.
Next Steps
- Restricted stock (940 shares) will vest over a 3-year period (25% on first anniversary, 25% on second, 50% on third anniversary of grant date).
- Stock options (3,400 options) will vest over a 3-year period (20% Year 1, 40% Year 2, 40% Year 3).
Key Dates
| Date | Description |
|---|---|
| 02/12/2025 | Grant date of restricted shares for which taxes were withheld on 02/12/2026. |
| 02/11/2026 | Acquisition of 940 restricted shares, vesting of 2,359 performance stock units, withholding of 1,085 shares for tax, and acquisition of 3,400 stock options. |
| 02/12/2026 | Withholding of 116 shares for tax on restricted shares. |
| 02/13/2026 | Signature date of the reporting person's attorney-in-fact. |
| 02/11/2036 | Expiration date of the 3,400 stock options. |
Keywords
Balchem Corporation, BCPC, Form 4, insider transaction, restricted stock, performance stock units, stock options, executive compensation, equity grant, tax withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.